Company

E&S Healthcare promises a healthier life for mankind.

Company history

2023

11

Breast Cancer In Vitro Diagnostic Kit, 'DxMe® BC Kit,' designated as a World-Class Product in Korea(Minstry of Trade, industry and Energy)

10

DxMe® BC Breast Cancer Diagnostic Kit, designated as an innovative medical device (Ministry of Food and Drug Safety)

06

Certification of Korea Good Manufacturing Practice of In-Vitro Diagnostic Devices (KGMP, MFDS)

04

The 4th investment attraction of 2.2 billion

2022

12

Designated as a KRIBB family company

10

Relocation of headquarters (International Science Business Belt_Dungok District)

08

Designated as a high-tech company (Ministry of Science and Technology Information and Communication)

07

Venture business confirmation certification (5th round)

06

DxMe®BC Kit won the grand prize in the tumor marker cancer diagnosis category of the American Clinical Association (AACC)

04

The 3rd investment attraction of 3 billion

2021

07

Inno-Biz certification (Inno-Biz, Ministry of SMEs and Startups)

02

ISO 13485: 2016 (Medical device-quality management system) certification (BSI, UK Malaysia registration of DxMe®BC Kit

01

Registered as a small business in the United States

2020

07

Venture company certificate

06

Certification of medical device manufacturing and quality control standards (KGMP, MFDS) ELSURETM(ELISA automated equipment) mass production model under development Selected as a technology commercialization capability enhancement project in 2020

01

Demeonstration and R&D Projet for promotion of Regulation Free Special Zone

2019

12

Certification of special case for demonstration in the Regulation Free Zone

08

Secondary investment of KRW 9 billion

07

Designated as a start-up leap package support project

2018

09

Registered as a small business in the United States

08

Inno-Biz certification (Inno-Biz, Ministry of SMEs and Startups)

07

Venture company certificate

06

Malaysian government-supported DxMe® BC breast cancer diagnostic kit demonstration

02

ISO 13485: 2016 (Medical device-quality management system) certification (BSI, UK)

2017

12

Preparation for Malaysian government-supported DxMe® BC breast cancer diagnostic kit demonstration

10

Application for permit of DxMe® BC Breast Cancer Diagnostic Kit in Brazil (ANVISA)

04

Designated as Research and Business Development (R&BD) by the Ministry of Commerce, Industry and Energy (Organizing institution)

01

Cooperation with Sao Paulo University in Brazil to advance into the South American market

2016

11

Primary investment of KRW 2.6 billion

09

Launched breast cancer screening project with Malaysian Cancer Foundation

07

Venture company certificate

05

Certification of medical device manufacturing and quality control standards (KGMP, MFDS)

02

Registered DxMe® BC breast cancer diagnostic kit in Netherlands, and Europe

2015

11

CE Marking

08

Item (for export) permission (MFDS) Medical device manufacturing permit (MFDS)

03

ISO13485 (Medical device-quality management system) certification (TÜV SÜD)

2014

07

Venture company certificate

06

Recognized as an affiliated Research Institute of E&S Healthcare Co., Ltd.

02

Acquisition of GMP production facility

2013

12

Signed technology transfer agreement with Pai Chai University Industry-Academic Cooperation Center

11

Founded